QCM
INDV icon

Quantinno Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Quantinno Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336K Buy
11,027
+2,157
+24% +$71.2K ﹤0.01% 2971
2025
Q4 		$318K Buy
+8,870
New +$271K ﹤0.01% 2794

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quantinno Capital Management's INDV Position: Q1 2026 in Review

Quantinno Capital Management increased its Indivior Pharmaceuticals (INDV) stake by 24% in Q1 2026, buying an estimated $71.2K and bringing the position to 11,027 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2971.

Quantinno Capital Management first reported a position in INDV in Q4 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Quantinno Capital Management held 11,027 shares of Indivior Pharmaceuticals worth $336K as of Q1 2026.
  • Quantinno Capital Management bought 2,157 Indivior Pharmaceuticals shares in Q1 2026, an estimated $71.2K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2971 holding.
  • Quantinno Capital Management first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.